Stockscreener 앱 받기
4.65
5.62%
-0.2771
시간 외 거래:
4.88
0.23
+4.95%
전일 마감가:
$4.9271
열려 있는:
$4.93
하루 거래량:
19,808
Relative Volume:
0.72
시가총액:
$3.17M
수익:
-
순이익/손실:
$-11.27M
주가수익비율:
-0.2172
EPS:
-21.4132
순현금흐름:
$-9.40M
1주 성능:
-18.85%
1개월 성능:
-20.24%
6개월 성능:
-65.56%
1년 성능:
-70.00%
1일 변동 폭
$4.59
$5.02
1주일 범위
$4.59
$5.77
52주 변동 폭
$4.59
$23.70
Dermata Therapeutics Inc Stock (DRMA) Company Profile
명칭
Dermata Therapeutics Inc
전화
(858)-223-0882
주소
3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO
DRMA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DRMA
Dermata Therapeutics Inc
|
4.65 | 3.36M | 0 | -11.27M | -9.40M | -21.41 |
|
VRTX
Vertex Pharmaceuticals Inc
|
381.87 | 96.56B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.58 | 60.08B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
555.51 | 61.15B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
711.09 | 44.66B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
328.71 | 36.23B | 3.81B | -644.79M | -669.77M | -6.24 |
Dermata Therapeutics Inc 주식(DRMA)의 최신 뉴스
News impact scoring models applied to Dermata Therapeutics Inc. Equity WarrantMarket Risk Analysis & Pattern Based Trade Signal System - newser.com
What the charts say about Dermata Therapeutics Inc. Equity Warrant todayMarket Risk Summary & Daily Entry Point Trade Alerts - newser.com
Comparing Dermata Therapeutics Inc. in custom built stock radarsTrade Analysis Report & Expert Approved Momentum Ideas - newser.com
Dermata Therapeutics Inc. stock trendline breakdownJuly 2025 Chart Watch & Advanced Swing Trade Entry Alerts - newser.com
Using data filters to optimize entry into Dermata Therapeutics Inc. Equity WarrantWeekly Risk Report & Target Return Focused Picks - newser.com
Measuring Dermata Therapeutics Inc. Equity Warrant’s beta against major indicesVolume Spike & AI Driven Price Forecasts - newser.com
Advanced analytics toolkit walkthrough for Dermata Therapeutics Inc.July 2025 Decliners & Weekly High Potential Stock Alerts - newser.com
What momentum shifts mean for Dermata Therapeutics Inc. Equity WarrantQuarterly Profit Summary & Weekly Top Performers Watchlists - newser.com
Using data tools to time your Dermata Therapeutics Inc. Equity Warrant exitEarnings Overview Summary & Weekly High Return Opportunities - newser.com
Is NWFL forming a reversal patternMarket Activity Recap & Community Verified Watchlist Alerts - newser.com
Real time breakdown of Dermata Therapeutics Inc. stock performance2025 Big Picture & Real-Time Price Movement Reports - newser.com
Buyout Rumor: Whats the profit margin of GSRTUJuly 2025 PostEarnings & Accurate Intraday Trade Tips - khodrobank.com
Intraday pattern recognizer results for Dermata Therapeutics Inc.Weekly Trade Analysis & Low Risk High Reward Trade Ideas - newser.com
How hedge fund analytics apply to Dermata Therapeutics Inc. stockJuly 2025 WrapUp & Weekly Sector Rotation Insights - newser.com
Visual analytics tools that track Dermata Therapeutics Inc. Equity Warrant performanceOptions Play & Community Driven Trade Alerts - newser.com
Why Dermata Therapeutics Inc. Equity Warrant is moving todaySwing Trade & Daily Price Action Insights - newser.com
EPS Watch: Is Dermata Therapeutics Inc Equity Warrant benefiting from innovation trends2025 Risk Factors & Stock Portfolio Risk Management - خودرو بانک
Will Dermata Therapeutics Inc. price bounce be sustainableJuly 2025 Closing Moves & AI Powered Buy/Sell Recommendations - newser.com
Fed Meeting: Is WOLF stock a falling knife or bargain buyWeekly Investment Summary & Expert Curated Trade Ideas - khodrobank.com
Visual analytics tools that track Dermata Therapeutics Inc. performanceLong Setup & Risk Controlled Daily Trade Plans - newser.com
Real time scanner hits for Dermata Therapeutics Inc. explainedTrend Reversal & Expert Approved Momentum Ideas - newser.com
Can swing trading help recover from Dermata Therapeutics Inc. lossesDip Buying & Fast Momentum Stock Entry Tips - newser.com
Exit strategy if you’re trapped in Dermata Therapeutics Inc.Trend Reversal & Risk Adjusted Buy/Sell Alerts - newser.com
What institutional flow reveals about Dermata Therapeutics Inc.Portfolio Growth Summary & Daily Growth Stock Tips - newser.com
Is it too late to sell Dermata Therapeutics Inc.Trade Analysis Report & Daily Risk Controlled Trade Plans - newser.com
Tools to assess Dermata Therapeutics Inc.’s risk profileJuly 2025 Patterns & Risk Controlled Stock Pick Alerts - newser.com
Trend Report: Will BNGO stock benefit from M AEntry Point & Consistent Income Trade Recommendations - khodrobank.com
Will Dermata Therapeutics Inc benefit from AI trendsJuly 2025 Drop Watch & Stock Timing and Entry Methods - خودرو بانک
Earnings Risk: Should I buy PSMT stock nowMarket Growth Summary & Safe Capital Growth Tips - khodrobank.com
Aug Breakouts: Whats the outlook for Universal Safety Products Incs sectorJuly 2025 PostEarnings & Free High Accuracy Swing Entry Alerts - khodrobank.com
Quarterly Trades: Can Dermata Therapeutics Inc navigate macro headwindsJuly 2025 WrapUp & Weekly Market Pulse Updates - خودرو بانک
Insider Buy: What is Dermata Therapeutics Inc.’s market positionInsider Selling & Free Growth Oriented Trading Recommendations - خودرو بانک
Moving Averages: Is SenesTech Inc. stock a good pick for beginnersTake Profit & Fast Moving Stock Watchlists - خودرو بانک
Will Dermata Therapeutics Inc. outperform the market2025 Market Trends & Technical Confirmation Trade Alerts - newser.com
Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing - GlobeNewswire
Dermata Therapeutics Presents Promising Phase 3 Trial Results - TipRanks
Market reaction to Dermata Therapeutics Inc. Equity Warrant’s recent newsPortfolio Gains Report & Risk Controlled Stock Pick Alerts - newser.com
Sentiment Review: What is the dividend yield of Dermata Therapeutics Inc. Equity Warrant2025 EndofYear Setup & Free Low Drawdown Momentum Trade Ideas - خودرو بانک
Dermata Therapeutics Announces Presentation of Abstract at the European Academy of Dermatology and Venereology Congress 2025 - ACCESS Newswire
Dermata to Present Phase 3 XYNGARI Acne Trial Data at EADV 2025 | DRMA Stock News - Stock Titan
Will Dermata Therapeutics Inc. Equity Warrant stock recover after recent dropJuly 2025 PreEarnings & Precise Buy Zone Identification - newser.com
Options Flow: Will BFS.PRD benefit from seasonality2025 Risk Factors & Low Volatility Stock Suggestions - خودرو بانک
Investor Mood: Is Dermata Therapeutics Inc in accumulation or distribution phaseMarket Growth Report & Risk Controlled Daily Plans - خودرو بانک
Market Rankings: Can Dermata Therapeutics Inc Equity Warrant generate free cash flow2025 Market Sentiment & Real-Time Volume Surge Alerts - خودرو بانک
Dermata Therapeutics to Present at the Life Sciences Virtual Investor Forum September 18th - GlobeNewswire
Life Science Virtual Investor Forum Agenda Announced for September 18th - GlobeNewswire
Support Test: Is SNBR currently under institutional pressureWeekly Earnings Recap & Weekly Top Stock Performers List - خودرو بانک
Dermata Therapeutics Inc (DRMA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.43%
자본화:
|
볼륨(24시간):